Cargando…
Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
Anticoagulation is needed for stroke prevention in patients with atrial fibrillation. Antiplatelet therapy is essential for the prevention of stent thrombosis and the reduction of cardiovascular events in patients who undergo coronary stenting and suffer acute coronary syndromes. When these conditio...
Autores principales: | Carreras, Edward T., Mega, Jessica L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107432/ https://www.ncbi.nlm.nih.gov/pubmed/25135291 http://dx.doi.org/10.1007/s40119-013-0015-2 |
Ejemplares similares
-
Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review
por: Magnani, Giulia, et al.
Publicado: (2023) -
Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents
por: Zullo, Angelo, et al.
Publicado: (2017) -
Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics
por: Beitelshees, Amber L, et al.
Publicado: (2015) -
Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
por: Mischke, Karl, et al.
Publicado: (2012) -
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)